Kidney Failure, Chronic: all 2,121 studies
Page 21 of 22. Open to participants first (264), then studies with results posted, then the rest; newest registration first within each.
- A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis PatientsCompletedNCT00261521Phase 3
- Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis PatientsCompletedNCT00259025Phase 2
- Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic HemodialysisCompletedNCT00257283Phase 4
- Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.CompletedNCT00255619Phase 4
- Anabolic Steroids and Exercise in Hemodialysis PatientsCompletedNCT00250536Not applicable
- Transplant and Addiction Project (TAP) - 1CompletedNCT00249652Phase 1/2
- The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis PatientsStatus unknownNCT00247507Phase 4
- Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart SurgeryCompletedNCT00244530Phase 4
- Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis PatientsCompletedNCT00244075Phase 2
- Aluminum and Auditory Function in ESRDStatus unknownNCT00243958
- Transplant Patient Registry of Liver, Kidney and/or PancreasCompletedNCT00238693
- Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal AnemiaStatus unknownNCT00238043Phase 3
- Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on DialysisCompletedNCT00236964Phase 3
- Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney DiseaseStatus unknownNCT00235287Phase 4
- The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy VolunteersCompletedNCT00234156Not applicable
- The Effect of Nighttime Dialysis on the Inflammation of Kidney FailureTerminatedNCT00234130Not applicable
- Efficacy and Safety Study of GerEPOCompletedNCT00229099Phase 3
- Peginesatide for Anemia in Chronic Hemodialysis PatientsCompletedNCT00228449Phase 2
- Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease PatientsCompletedNCT00228436Phase 2
- CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft RecipientsCompletedNCT00227045
- Vascular Reactivity in Kidney Disease PatientsCompletedNCT00226902Not applicable
- DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)CompletedNCT00224081Phase 4
- Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric PatientsCompletedNCT00221845Phase 3
- Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis EfficiencyCompletedNCT00221598Not applicable
- The Effects of Cool Dialysate on the Sleep/Wake Cycle in Patients on Chronic Hemodialysis - "The Sleep Cool Study"CompletedNCT00218790Not applicable
- A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal DialysisCompletedNCT00214721Phase 3
- A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal DialysisCompletedNCT00214695Not applicable
- Darbepoetin Treatment of Anemia in Children With Chronic Renal FailureCompletedNCT00213291Phase 3
- Evaluation of Manufacturing Lot of StaphVAXCompletedNCT00211900Phase 3
- Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another ErythropoietinCompletedNCT00210951
- Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis PatientsCompletedNCT00205556Not applicable
- Intravenous Iron in Patients With Anemia of Chronic Kidney DiseaseStatus unknownNCT00204256Phase 4
- MMF and Calcineurin Inhibitor Withdrawal in CANTerminatedNCT00204230Not applicable
- The Fish and Fruit Study: Trial of Fish and Fruit to Improve Survival of Aboriginal People With End Stage Renal DiseaseCompletedNCT00192543Phase 3
- Phosphate Intake's Effect on the Skeletal System - PilotCompletedNCT00187629Not applicable
- Growth Hormone Treatment in Adult Patients With Chronic Kidney DiseaseCompletedNCT00184652Phase 2
- The Vienna Prograf and Endothelial Progenitor Cell StudyCompletedNCT00182559Phase 4
- Cohort Study Comparing Short Daily Hemodialysis (HD) With Conventional HDWithdrawnNCT00182156
- Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis PopulationStatus unknownNCT00182117
- The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis PatientsCompletedNCT00179218Phase 2
- Complementary Intradialytic Nutritional Supplementation in Dialysis PatientsTerminatedNCT00179205Phase 2
- Prevention and Treatment of Hemodialysis Vascular Access MalfunctionWithdrawnNCT00179192Phase 2
- The Effects of Nutrition Supplementation and Resistance Exercise During HemodialysisCompletedNCT00179179Phase 2
- Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of TennesseeCompletedNCT00179153Phase 2
- The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis PatientsCompletedNCT00179140Phase 2
- Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant RecipientsCompletedNCT00176059Early Phase 1
- Prevention of Contrast-Induced NephropathyCompletedNCT00175227Not applicable
- Collection of Blood and Urine Specimens From Volunteers Utilizing Health Examination ServicesStatus unknownNCT00173940
- Malnutrition and Inflammation in Dialysis Patients in TaiwanStatus unknownNCT00173823
- Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal DiseaseCompletedNCT00172809Phase 4
- Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?Status unknownNCT00172302Not applicable
- Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis PatientsCompletedNCT00172211Not applicable
- Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney TransplantWithdrawnNCT00167791Not applicable
- Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol InhalationStatus unknownNCT00162487Not applicable
- Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis PatientsCompletedNCT00161369
- Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal DiseaseCompletedNCT00160121Phase 4
- Long Study - Longitudinal Thrombosis in End Stage Renal DiseaseStatus unknownNCT00157664
- Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis CathetersCompletedNCT00157651Phase 3
- Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical PrognosisStatus unknownNCT00155363Phase 4
- Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected PatientsCompletedNCT00153621
- Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving DialysisCompletedNCT00151931Phase 3
- Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal DiseaseCompletedNCT00151918Phase 3
- Effects of Daily Home Hemodialysis on Circulation, Mental Functions, and Quality of LifeCompletedNCT00150956Phase 3
- Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant RejectionCompletedNCT00150891
- Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their BloodCompletedNCT00150566Phase 3
- A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.CompletedNCT00150540Phase 3
- Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody TitersCompletedNCT00143741Phase 1
- Sodium-Endothelial Function-CKD StudyCompletedNCT00141622Not applicable
- Haemodialysis Salt Reduction StudyCompletedNCT00141609Not applicable
- Effects of Cyclosporine A on Pancreatic Insulin SecretionCompletedNCT00139035Phase 4
- Overcoming Nutritional Barriers in Hemodialysis PatientsCompletedNCT00136253Not applicable
- Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access GraftsTerminatedNCT00131872Phase 2
- Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal DiseaseTerminatedNCT00130260Phase 3
- Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?CompletedNCT00125775Phase 4
- Influence of Amlodipine on the Mortality of Patients With End-Stage Renal FailureCompletedNCT00124969Phase 4
- An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac SurgeryCompletedNCT00122018Phase 2
- To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic NephropathyTerminatedNCT00120328Phase 3
- Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic HemodialysisCompletedNCT00117104Phase 4
- SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary HyperparathyroidismCompletedNCT00117052Phase 3
- Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) LevelsCompletedNCT00113958Phase 2
- Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)CompletedNCT00113945Phase 2
- Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving HemodialysisCompletedNCT00111995Phase 4
- Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)CompletedNCT00110929Phase 2
- Safety of Single Doses of Peginesatide in Patients With Chronic Kidney DiseaseTerminatedNCT00109291Phase 2
- Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy VolunteersCompletedNCT00097747Phase 1
- A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)CompletedNCT00097617
- Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on HemodialysisCompletedNCT00091481Phase 4
- Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%TerminatedNCT00090194Phase 2
- Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring HemodialysisTerminatedNCT00086164Phase 1/2
- Patient-Provider Trust Among Individuals With End-Stage Kidney DiseaseCompletedNCT00075036
- A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on HaemodialysisCompletedNCT00074620Phase 2
- Study to Evaluate the Effectiveness of StaphVAX in Adults on HemodialysisCompletedNCT00071214Phase 3
- Role of Chronic Kidney Disease in Cardiovascular DiseaseWithdrawnNCT00069810
- Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow TransplantCompletedNCT00063817Phase 1
- Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on HemodialysisTerminatedNCT00062699Phase 4
- Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney FailureCompletedNCT00062621Phase 1
- Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on HemodialysisCompletedNCT00053547Phase 4
- Cardiac and Renal Disease Study (CARDS)CompletedNCT00049907
- Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant RecipientsCompletedNCT00044720Phase 4
- A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on DialysisCompletedNCT00042653Phase 3